Xencor | XNCR - Resultado Líquido





Resultado Líquido Alterar Data
AbbVie USD 1.82B 1.63B 2025-12
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
Amgen USD 1.33B 1.88B 2025-12
Arrowhead Research USD 30.81M 54.56M 2025-12
AstraZeneca USD 2.33B 207M 2025-12
Biogen USD 466.5M 168.3M 2025-09
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Cytokinetics USD -183.03M 123.15M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
J&J USD 5.12B 36M 2025-12
Karyopharm Therapeutics USD -102.2M 71.42M 2025-12
MacroGenics USD -14.16M 30.98M 2025-12
Merck USD 2.96B 2.82B 2025-12
Novartis USD 2.41B 1.52B 2025-12
Pfizer USD -1.65B 5.19B 2025-12
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Xencor USD -6.65M 626K 2025-12